Melanoma development and progression not only involve genetic and epigenetic changes that take place within the melanocytic cells, but also involve processes that are determined collectively by contextual factors including intercellular adhesions and communications. In this review, we focus on melanoma-stromal fibroblast crosstalk by direct cell-cell contact and by growth factors/ cytokines/chemokines interacting with their respective receptors. The interactions between melanoma cells and stromal fibroblasts create a context that promotes tumor growth, migration/invasion, and angiogenesis. An understanding of this process and developing new experimental and screening models are of great importance for the development of effective therapeutical strategies to treat melanoma.
In multicellular organisms, homeostasis is governed by three major forms of communications: (1) extracellular communication via soluble factors including hormones, growth factors, and cytokines; (2) intracellular communication via second messengers and complex signal transduction networks; and (3) intercellular communication via cell-cell adhesion and cell-matrix adhesion Li et al., 2002) . Together, these interactions provide the information that is critical to control normal cellular behavior and to maintain complex tissue structure (Bissell and Radisky, 2001) .
We now view melanoma as a complex tissue resulting from disrupted skin homeostasis, rather than focusing on the melanoma cell, and the genes within it, alone. Normal skin melanocytic homeostasis is maintained by dynamic interactions between the melanocytes (Mc) and their microenvironment, such as keratinocytes, fibroblasts, endothelial and immunocompetent cells, and the extracellular matrix. During transformation and progression of melanocytes to melanoma cells, there are, however, deregulated interactions between the neoplastic cells and the adjacent stromal cells. The characteristics of solid tumors, that is, uncontrolled proliferation, derangement of cellular and morphological differentiation, invasion, and colonization to distant organs, can be attributed, in part, to alterations in communications between neoplastic cells and the normal cells in their immediate microenvironment (Hanahan and Weinberg, 2000; Park et al., 2000) . Thus, skin cells within or surrounding the cancerous tissue are not idle bystanders, but rather active participants whose function in shaping the aggressive features of the neoplasm depends on the structural and functional aspects of the interactions (Bissell and Radisky, 2001; Herlyn, 2002; Li et al., 2002; Ruiter et al., 2002) . Although we have an increasingly good understanding of the genetics and biochemistry of these events, the mechanisms underlying their combinatorial interactions are still poorly defined and need to be fathomed to lead to more successful therapeutic strategies ultimately.
The development and migration of melanoblasts (Mb)/ Mc serves as a good example how microenvironmental factors affect the behavior of pigmented cells. Mc and their progenitors Mb are derived from the neural crest and migrate along the dorsolateral pathway to colonize the dermis, the epidermis, and finally the hair matrix (Nishimura et al., 1999; Pla et al., 2001) . Accordingly, the surrounding microenvironment changes sequentially during Mc development. For Mb, to migrate through such changing surroundings appropriately, the adhesive properties must be strictly regulated, both temporally and spatially (Perris, 1997; Pla et al., 2001) . Especially, the expression of cadherins on the surface of Mb is coordinated to be compatible with that of surrounding cells, such as keratinocytes and fibroblasts (Nishimura et al., 1999) .
Evidence exists that restored normal context could suppress the transformed phenotype (Javaherian et al., 1998; Olumi et al., 1999; Hsu et al., 2000b ) and lead to inhibition or even reversion of tumors in situ (Stoker et al., 1990; Deng et al., 1996; Bissell et al., 1999; Stoler et al., 1999; Frame and Balmain, 2000; Washington et al., 2000) . For example, when normal Mc are isolated from skin and then cultured, they display a bi-or tripolar morphology, and express cell surface molecules that are only found on melanoma cells in situ (ValyiNagy et al., 1993) . When Mc are mixed with keratinocytes to allow cell-cell contact, their growth becomes regulated and adjusted to the growth rates of keratinocytes. Expression of melanoma-associated antigens disappears in cocultures within 3-4 days (Valyi-Nagy et al., 1993; Hsu et al., 2000b; Li and Herlyn, 2000) . E-cadherin-negative melanoma cells are refractory to keratinocyte-mediated phenotypic control, which can be re-established by overexpressing E-cadherin in melanoma cells followed by coculture with keratinocytes .
The lack of understanding or consideration of tumormicroenvironment interactions, in part, underlies the inefficiency in drug screening processes or the failures in translating laboratory discoveries into clinically proven regimens to treat cancers. Therefore, it becomes increasingly critical to investigate and to take into serious consideration the effects of contextual factors on tumors, which, unfortunately, have been generally overlooked in the past.
The inhibitory effects of keratinocytes on melanoma have been extensively reviewed recently Li and Herlyn, 2000; Li et al., 2002) . This review will focus on the melanoma-stromal fibroblast interactions through direct contacts and through soluble factors during melanoma development Lazar-Molnar et al., 2000; Li and Herlyn, 2000; Satyamoorthy et al., 2001 Satyamoorthy et al., , 2002 . We also propose that the stromal fibroblasts can be derived from both resident fibroblasts surrounding the malignant cell mass and bone marrow-derived circulating mesenchymal stem cells. Lastly, we will briefly introduce an advanced human skin model -organotypic skin reconstruct -that offers both sophistication and convenience to study Mc/melanoma and their microenvironment.
Melanoma-stromal fibroblast interactions by direct contacts
Functional interactions between melanoma and stromal fibroblasts occur through direct cell-cell contacts mediated by cadherins (Gumbiner, 2000) and connexins (Hsu et al., 2000a) . During the transition from normal cells to benign and malignant lesions, then to metastatic cancer, stepwise changes in intercellular communications provide tumor cells with the ability to overcome microenvironmental controls from the host and to invade surrounding tissues and disperse to distant locations.
In normal human epidermis, E-cadherin is localized at the intercellular borders between keratinocytes and between keratinocytes and Mc (Tang et al., 1994) , and is the most critical molecule in the control of Mc by keratinocytes Li et al., 2002) (Figure 1a) . During melanoma development, there is a progressive loss of E-cadherin (Danen et al., 1996; Hsu et al., 1996; Silye et al., 1998) and gain of N-cadherin (Hsu et al., 1996; Sanders et al., 1999; Li et al., 2001a) , which not only frees melanoma cells from control by keratinocytes, but also provides new adhesion properties Li et al., 2001a) (Figure 1b) , promotes inappropriate survival signals and thus enhances the malignant phenotype (Hazan et al., 2000; Li et al., 2001a) .
The regulation, under normal or malignant conditions, of the state of adherens junctions can occur at different levels and through different mechanisms (Gumbiner, 2000) . In contrast to other cancer types (for review, see Hirohashi, 1998) , our studies (Li et al., 2001a and others (Poser et al., 2001) show that loss of E-cadherin in melanoma cell lines does not usually involve mutations in the E-cadherin gene or promoter methylation. Recently, two possible mechanisms for E-cadherin inactivation have been discovered. One involves aberrant expression of growth factor hepatocyte growth factor (HGF) (Li et al., 2001b) . HGF is a multifunctional cytokine acting as mitogen, motogen, and morphogen for many cell types (Nakamura et al., 1989) through its tyrosine kinase receptor cMet, which is present in epithelial cells and Mc (Bottaro et al., 1991; Sonnenberg et al., 1993; Li et al., 2001b) . HGF is physiologically secreted by cells of mesenchymal origin and acts on neighboring epithelial cells through a paracrine loop (Rosen et al., 1994) . Normal Mc do not produce HGF (Li et al., 2001b) . However, an HGF/cMet autocrine loop has been identified in melanoma cells, and shown to be involved in tumor development and invasion by downregulating E-cadherin and desmoglein 1 expression (Li et al., 2001b) . HGF/c-Met signaling has been previously implicated in the development of melanoma (Natali et al., 1993; Hendrix et al., 1998; Otsuka et al., 1998; Rusciano et al., 1998) ; however, the exact mechanisms are still largely unknown. Our study (Li et al., 2001b) provides strong evidence that downregulation of adhesion receptors with tumor-suppressor activity, in part, underlies the melanoma-promoting activity of HGF. Our discovery is supported by studies carried out in prostate cancer cell lines DU145 (Miura et al., 2001) and LNCapFGC (Davies et al., 2001) . Interestingly, the cadherin switch from E-to N-cadherin in epiblast cells can be recapitulated in vitro by treating the cells with HGF (DeLuca et al., 1999) .
Lately, it was found that the Snail family of zincfinger transcription factors repress E-cadherin expression by interacting with the E-pal element of the E-cadherin promoter through its E2-box sequence (Batlle et al., 2000; Cano et al., 2000) . Snail was originally implicated in the epithelial-mesenchymal transition required for the emigration of the neural crest from the neural tube and of the early mesoderm from the primitive streak during embryonic development (Nieto et al., 1994; Sefton et al., 1998) . Endogenous Snail protein is present in invasive mouse and human carcinoma cell lines and tumors in which Ecadherin expression has been lost (Batlle et al., 2000; Cano et al., 2000; Yokoyama et al., 2001) . Recent study by Hajra et al. (2002) showed that Slug (another member of Snail family of zinc-finger transcription factor; Savagner et al., 1997) represses E-cadherin in breast cancer cells. After screening a panel of melanoma cells from different progression stages, we ( Figure 2 ) and others (Poser et al., 2001) found out that the expression pattern of Snail negatively correlates with the expression of E-cadherin, while there is no clear correlation between the expression of Slug and E-cadherin (Figure 2) .
The phenomenon of cadherin class switching has been observed in various biological processes such as cell differentiation and migration (Edelman et al., 1983; Hatta and Takeichi, 1986; Nishimura et al., 1999; Jouneau et al., 2000) during embryonic development, and during tumor development (Hsu et al., 1996; Husmark et al., 1999; Kawamura-Kodama et al., 1999; Tran et al., 1999) .
What is the biological significance of the N-cadherin expressed in melanoma cells? It has been demonstrated that N-cadherin expression in melanoma cells allows communication with N-cadherin-expressing fibroblasts through gap junctions (Hsu et al., 2000a) . Anti-Ncadherin antibodies can delay the transendothelial migration of melanoma cells (Sandig et al., 1997; Voura et al., 1998) . Recently, studies carried out in our lab (Li et al., 2001a) show that N-cadherin mediates homotypic aggregation among melanoma cells as well as heterotypic adhesion of melanoma cells to dermal fibroblasts and vascular endothelial cells, which may improve their ability to migrate through stroma and enter the vasculature. N-cadherin-mediated cell adhesion activates antiapoptotic protein Akt/PKB and subsequently stabilizes b-catenin and inactivates the proapoptotic factor Bad (Li et al., 2001a) . Thus, cadherin subtype switching from E-to N-cadherin during melanoma development not only frees melanocytic cells from the control of keratinocytes but also provides growth and possibly metastatic advantages to melanoma cells . Similar observations were also made in breast cancer cells (Williams et al., 1994; Nieman et al., 1999; Hazan et al., 2000) .
As discussed earlier, E-cadherin is a 'tumor suppressor' for Mc transformation, while N-cadherin may been seen as a 'tumor promoter'. The next important question raised by these observations is: why do they have opposite effects on melanoma, while apparently (Hsu et al., 2000a; Li et al., 2002) , is a candidate participant whose functional involvement is being investigated. Therefore, it appears too simplistic to call cadherin molecules 'tumor suppressor' or 'invasion suppressor' (Birchmeier et al., 1995) . It is the interaction partnership, for example, the contextual relation, which is mediated by cadherins and other adhesion molecules that appears critical in determining the cellular behavior in a given microenvironmental setting.
Melanoma-stromal fibroblast interactions by soluble factors
Unlike normal Mc, melanoma cells constitutively produce a variety of growth factors and cytokines and their respective receptors that enable the cells to progress to a more aggressive phenotype Halaban, 1996; Meier et al., 1998; LazarMolnar et al., 2000) (Figure 3 ). Autocrine growth factors (bFGF, IL-8, HGF, PDGF-A) stimulate proliferation and migration of the melanoma cell itself. Paracrine growth factors (PDGF, TGF-b, bFGF, VEGF, MCP-1) modulate the microenvironment, especially stromal fibroblasts, to the benefit of melanoma growth, invasion, and metastasis. Melanoma-derived growth factors with stroma-inducing potential are bFGF, PDGF, and TGF-b. Expression of bFGF is upregulated in many human tumors including melanoma, with expression levels increasing during tumor progression (Albino et al., 1991; al-Alousi et al., 1996a,b) . An autocrine growth stimulatory role for bFGF in melanoma has been clearly established (Wang and Becker, 1997; Halaban et al., 1988; Nesbit et al., 1999; Meier et al., 2000) . bFGF is mitogenic not only for Mc but also for fibroblasts and endothelial cells. Thus, melanoma-derived bFGF has potential paracrine functions in stroma formation (Lazar-Molnar et al., 2000) . PDGF, on the other hand, is not produced for autocrine growth because the melanoma cells do not express the PDGF b receptor (Westermark et al., 1986; Forsberg et al., 1993) . Besides its mitogenic activity, (Ono et al., 1995; Pierce et al., 1995) . Furthermore, PDGF-activated fibroblasts produce IGF-I for stimulation of the malignant cells, which express the IGF-1 receptor . TGF-b is yet another growth factor secreted by melanoma cells (Reed et al., 1994; Rodeck et al., 1994; Van Belle et al., 1996; Krasagakis et al., 1999; Massague et al., 2000) , and not by normal Mc, which functions mainly to stimulate stromal fibroblasts surrounding melanoma lesions . TGF-b is a negative growth factor for epithelial cells and normal Mc (Massague et al., 2000) ; however, melanoma cells develop various degrees of resistance to TGF-b-induced inhibition of DNA synthesis (Rodeck et al., 1994; . Recently, we have shown that melanoma cells can modulate their surrounding stroma for their own benefits through the paracrine activity of TGF-b1 (Figure 4) . Stimulation of ECM protein production by stromal fibroblasts provided a scaffolding for the melanoma cells, which showed increased survival and metastasis in SCID mice .
Conversely, fibroblasts are also a rich source of growth factors (Figure 3 ), but only after activation (Halaban, 1996) . When stimulated, for example by melanoma cells through PDGF, fibroblasts can produce a pool of growth factors (IGF-1, HGF, bFGF and ET-3). For normal Mc, benign nevus cells, and melanoma cells from the RGP and early VGP stage, IGF-1 is one of the most critical growth factors required for survival and growth of cells in chemically defined media (Herlyn et al., 1985; Stracke et al., 1989; Satyamoorthy et al., 1997) . IGF-1 receptor (IGF-IR) is expressed by all melanocytic cells , and the expression increases with progression (Kanter-Lewensohn et al., 1998). Melanoma cells apparently rely on IGF-1 secreted by fibroblasts because they do not produce it on their own. Recent data indicate that IGF-1 enhances survival, migration, and growth of cells from biologically early lesions but not from biologically late primary or metastatic lesions . Early melanoma cells are activated by IGF-1 to phosphorylate Erk 1 and 2 of the MAP kinase pathway. IGF-1 also activates Akt, inhibits its downstream effector GSK3-b, and stabilizes b-catenin (Satyamoorthy et al., 2001). Late primary and metastatic melanoma cells do not respond to growth stimulation by IGF-1 because of a constitutive activation of the MAP kinase pathway and a higher level of stabilized bcatenin. A most recent study combining microarray and biochemical analyses shows that fibroblast-derived IGF-1 can induce IL-8 expression in melanoma cells, especially in early-stage melanomas, through MAP kinase/JNK/c-Jun/AP-1 pathway (Figure 5 ). Antibody blockage of IL-8 signaling can abolish IGF-I-induced cell migration, suggesting that the motility effect of IGF-I on melanoma is mediated by subsequent events of IL-8 induction and autocrine stimulation. The possibility that angiogenic effect of IGF-I is also mediated by IL-8 induction is hinted by the discovery that VEGF expression can also be elevated by IGF-1 treatment ( Figure 5 ) (Akagi et al., 1998; Bermont et al., 2000; Satyamoorthy et al., 2002) . 
Sources of stromal fibroblasts
The involvement of fibroblasts in tumor stroma requires a dynamic process of attraction, proliferation, and differentiation (Ruiter et al., 2002) . On the basis of recent studies on stroma formation and tumor-stroma interaction (Gabbiani, 1996; Powell et al., 1999; Rafii, 2000; Elenbaas and Weinberg, 2001) , as well as an exponentially enlarged body of knowledge on stem cell biology (Blau et al., 2001) , we propose that the stromal fibroblasts in tumors are derived from either recruited resident fibroblasts or circulating mesenchymal precursors or mesenchymal stem cells derived from bone marrow ( Figure 6 ). Regardless of the origins of fibroblasts, these cells then undergo activation and proliferation. Activated fibroblasts then can go back to resident status, or convert into myofibroblasts, or differentiate into fibrocytes that secrete ECM components, or pericytes that facilitate vasculature formation. Currently, very little is known about the dynamics of fibroblast involvement and the molecules that regulate it.
A model system that cares about context: organotypic skin reconstructs Most of current in vitro experiments on human skin and melanoma utilize monocultured cell lines in Petri dish. However, as discussed earlier, the behavior of the cells under this condition is usually very different from that of the cells in vivo (Herlyn et al., 1987; Javaherian et al., 1998; Vaccariello et al., 1999; Hsu et al., 2000b) . To mimic maximally the natural skin structure and maintain physiological context, several organotypic skin reconstruction models have been developed to investigate the biological properties of normal human Mc and melanoma (Todd et al., 1993; Archambault et al., 1995; Nakazawa et al., 1997; Meier et al., 2000) . Human skin reconstructs are threedimensional in vitro models consisting of epidermal keratinocytes and Mc plated onto fibroblast-contracted collagen gels. Cells in skin reconstructs more closely recapitulate the in situ phenotype than do cells in monolayer culture (Figure 7 ). Normal Mc in skin reconstructs remained singly distributed at the basement membrane that separated the 'epidermis' from the 'dermis' (Figure 7a ). Cell lines derived from RGP melanomas proliferate in the epidermis only without infiltrating basement membrane (Figure 7b ), while VGP and metastatic melanoma lines invade the reconstructed dermis (Figure 7c, d ) Bechetoille et al., 2000; Eves et al., 2000; Meier et al., 2000; ). The development of organotypic reconstructs of human skin, in which culture artefacts are greatly diminished and cell-matrix and cell-cell interactions between different cell types can be investigated in a three-dimensional system, has provided a powerful new tool for melanoma research.
Conclusion
Accumulating evidence has demonstrated the importance of tumor microenvironment on the behaviors of the malignant cells. While a restored normal tissue context may suppress or inhibit malignant transformation (Stoker et al., 1990; Javaherian et al., 1998; Bissell et al., 1999; Hsu et al., 2000b; Olumi et al., 1999; Stoler et al., 1999; Frame and Balmain, 2000; Washington et al., 2000) , activated stroma could function as a tumor promoter (Mintz and Silvers, 1993; Thomasset et al., 1998; Barcellos-Hoff and Ravani, 2000; Moinfar et al., 2000; Li et al., 2001a; Tlsty, 2001 ; Satyamoorthy et al., Figure 6 Proposed sources of fibroblasts in melanoma stroma. Activated fibroblasts in melanoma stroma may be derived from either the resident pool in the dermis, or from bone marrow-derived circulating mesenchymal stem cells. Upon activation, the fibroblasts can proliferate, and may further differentiate into specialized cells such as myofibroblasts, pericytes, and fibrocytes, or become quiescent Melanoma-fibroblast interactions in melanoma development G Li et al 2001 . Therefore, targeting the tumor stroma offers an important new direction and potential for future cancer therapies (Sporn, 1996; Sporn and Suh, 2000; Bissell and Radisky, 2001) . It is conceivable that effective anticancer drugs would be able both to restrain or destroy the tumor cells and to restore the normal context as well.
